Venetoclax Shows Promise as AML Treatment Option Venetoclax Shows Promise as AML Treatment Option
Venetoclax treatment combinations show benefit as first-line and follow-up therapy for adults with acute myeloid leukemia and for patients who relapse after receiving allogeneic stem cell transplants.First Look
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Hematology | Leukemia | Stem Cell Therapy | Stem Cells | Transplants